Roche’s Hemlibra Battles Fierce Competition Amid Rating Hold
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
- Latest
- Trending
Roche's Hemlibra braces for fierce competition from Novo Nordisk's mim8, as analysts give mixed ratings and forecasts on Roche's strategic ...
Iovance Biotherapeutics has the potential to become a multiproduct company, and even if its stock doesn't soar quickly, it's still ...
Consider investing in AbbVie and e.l.f., two names with significant growth potential in 2024. AbbVie shines as a quality business ...
Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
A majority of patients believe that when used properly, AI can enhance healthcare. However, many are wary of its increasing ...
The article argues for creators to focus on building meaningful and fun gaming projects rather than just tokens. It emphasizes ...
Buterin criticizes the dominance of meme coins in the crypto world, pointing out their lack of real-world utility and overshadowing ...
Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
Artur has developed "live forever mode," a virtual reality tool. Somnium Space, a 3D metaverse platform, caters to children. Privacy ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.